New Strategies for Reducing Cardiovascular Risk in CKD with T2D: Development of Finer Mineralocorticoid Antagonists
Sign In Please sign in with the same email you registered with. If you do not have an account please register here. Account Information Email Address: * Remember Me: Remember me?